Dr. Heidi Overton, who was nominated to be the FDA commissioner, has agreed to create a timeline for a safety study on the abortion pill mifepristone. This commitment follows pressure from Senator Josh Hawley, who has been advocating for accountability regarding the drug's safety. The study will review data from before and after the Biden administration lifted certain restrictions on mifepristone. Overton's nomination was withdrawn just before a Senate committee vote, and the FDA's review has experienced multiple delays.
Key facts
- Dr. Heidi Overton committed to a safety study on mifepristone.
- Senator Josh Hawley has been advocating for accountability on the drug's safety.
- The Trump administration pledged to finalize a safety study by March 2027.
- The FDA's review of mifepristone has faced repeated delays.
- Overton's nomination was withdrawn before a Senate committee vote.
A short AI summary in our own words. The reporting belongs to Fox News — Politics; we don't reproduce it.